Frontiers in Oncology (Feb 2024)

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

  • Serena Vita,
  • Alessandra D’Abramo,
  • Andrea Coppola,
  • Chiara Farroni,
  • Anna Paola Iori,
  • Francesca Faraglia,
  • Alessandro Sette,
  • Alba Grifoni,
  • Cecilia Lindestam Arlehamn,
  • Michele Bibas,
  • Delia Goletti,
  • Emanuele Nicastri

DOI
https://doi.org/10.3389/fonc.2024.1290614
Journal volume & issue
Vol. 14

Abstract

Read online

Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.

Keywords